Commercializing RNAi With Tolga Tanguler
Source: Life Science Leader
In this chapter of Business of Biotech episode 252, Alnylam Chief Commercial Officer Tolga Tanguler addresses challenges and opportunities in the RNAi therapeutics commercialization effort. Catch the full episode here!
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader